Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer.
Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Chemokine CXCL12
Cyclin D1
Drug Resistance, Neoplasm
ErbB Receptors
Erlotinib Hydrochloride
Female
Humans
Mice
Mice, Nude
Neoplasm Transplantation
Pancreatic Neoplasms
Phosphatidylinositol 3-Kinases
Phosphorylation
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-myc
Pyridines
Quinazolines
Receptors, CXCR
Receptors, CXCR4
RNA Interference
RNA, Small Interfering
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases
Transplantation, Heterologous
Tumor Microenvironment
Vascular Endothelial Growth Factor A
authors with profiles
Elizabeth Garrett Garrett-Mayer